Dr. Raphael Krampe

Dr. Raphael Krampe, Boehringer Ingelheim microParts - Qepler Summits And Conferences

Dr. Raphael Krampe

Scientist
Boehringer Ingelheim microParts
Ratingen, Germany
Boehringer Ingelheim microParts

Raphael Krampe is a pharmacist by training.

After his studies he joined the department of pharmaceutics at the university of Florida for a research stay. He received his Ph.D. in pharmaceutics and biopharmaceutics from the Heinrich Heine University at Düsseldorf.

In 2016 he joined Boehringer Ingelheim microparts in Dortmund. His work focusses on device development, life cycle management and design verification of the Soft Mist Inhaler Respimat®.

Related Sessions:

Qepler - Drug/Device Combination Products Summit thumbnail Details

Drug/Device Combination
Products Summit 2018

Get up to date with the regulatory and quality compliance strategies for combination product development.
  • 04 Dec 2018
  • Berlin, DE
  • Pharma
Day 2: Wednesday, 05 December 2018
BLOCK: INTEGRATING DESIGN CONTROL AND HUMAN FACTORS.
CASE STUDY: Life Cycle Management of the Soft Mist Inhaler Respimat®.
  • Profile of a perfect inhaler
  • Challenges of combination products
  • Respimat – Design and main subassemblies
  • Device-performance and User-requirements
  • Carbon footprint
View Details
Qepler - Inhaled Drug Delivery Summit thumbnail Details

Inhaled Drug Delivery
Summit 2019

Assess and harness novel approaches to the development of inhaled drug products for enhanced patient care.
  • 23 May 2019
  • Berlin, DE
  • Pharma
Day 2: Friday, 24 May 2019
BLOCK: FORMULATION, DEVELOPMENT & DESIGN.
CASE STUDY: The Soft Mist Inhaler Respimat® - Performance and test requirements.
  • Respimat platform – Subassemblies and performance
  • Carbon footprint as development goal
  • Test requirements – Design verification according to ISO 20072
View Details
Qepler - 2nd Annual Drug/Device Combination Products Summit thumbnail Details

2nd Annual Drug/Device
Combination Products Summit 2019

Get up to date with the regulatory and quality compliance strategies for combination product development.
  • 04 Dec 2019
  • Prague, CZ
  • Pharma
Day 2: Thursday, 05 December 2019
CASE STUDY: The re-usable Respimat – Eco-friendly Inhaler with robust technical performance and improved usability.
  • Carbon footprint as a development goal
  • Optimization of the successful soft mist inhaler Respimat
  • Technical performance and Usability (Human factors)
  • Synergism of device and cartridge
View Details
This website stores cookies on your computer. These cookies are used to collect information about how you interact with our website and allow us to remember you. We use this information in order to improve and customize your browsing experience and for analytics and metrics about our visitors both on this website and other media. To find out more about the cookies we use, see our Cookies Policy.